Concord Medical Services (CCM)
(Real Time Quote from BATS)
$7.01 USD
-0.16 (-2.23%)
Updated Aug 22, 2024 03:43 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Concord Medical Services Holdings Limited falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 76 | 68 | 76 | 34 | 28 |
Cost Of Goods | 86 | 91 | 85 | 32 | 31 |
Gross Profit | -11 | -22 | -9 | 2 | -2 |
Selling & Adminstrative & Depr. & Amort Expenses | 54 | 54 | 63 | 50 | 61 |
Income After Depreciation & Amortization | -65 | -76 | -72 | -48 | -63 |
Non-Operating Income | 10 | -28 | 0 | -7 | 11 |
Interest Expense | 23 | 17 | 12 | 12 | 4 |
Pretax Income | -78 | -122 | -83 | -68 | -56 |
Income Taxes | -3 | -10 | -1 | -6 | -6 |
Minority Interest | -33 | -41 | -39 | -14 | -6 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -75 | -111 | -82 | -62 | -51 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -42 | -71 | -43 | -48 | -44 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -47 | -57 | -56 | -36 | -55 |
Depreciation & Amortization (Cash Flow) | 18 | 19 | 16 | 12 | 8 |
Income After Depreciation & Amortization | -65 | -76 | -72 | -48 | -63 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 4.37 | 4.37 | 4.37 | 4.37 | 4.34 |
Diluted EPS Before Non-Recurring Items | -9.60 | -16.20 | -29.40 | -23.40 | -18.30 |
Diluted Net EPS (GAAP) | -9.60 | -16.20 | -29.40 | -23.50 | -18.30 |
Fiscal Year end for Concord Medical Services Holdings Limited falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |